CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of CinCor Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. CinCor Pharma Inc market cap is $1.27B.
What is the 52-week high for CinCor Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. CinCor Pharma Inc 52 week high is $43.15 as of September 28, 2025.
What is the 52-week low for CinCor Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CinCor Pharma Inc 52 week low is $10.53 as of September 28, 2025.
What is CinCor Pharma Inc stock price today?
CinCor Pharma Inc stock price today is $29.14.
What was CinCor Pharma Inc stock price yesterday?
CinCor Pharma Inc stock price yesterday was $29.20.
What is the PE ratio of CinCor Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. CinCor Pharma Inc’s P/E ratio is -12.67.
What is the Price-to-Book ratio of CinCor Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. CinCor Pharma Inc P/B ratio is 2.4508.
What is the 50-day moving average of CinCor Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. CinCor Pharma Inc 50-day moving average is $23.15.
